Colonic Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
947
|
45
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
ESTROGEN RESISTANCE
|
disease |
|
Disease or Syndrome
|
30
|
7
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2010 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Lip and Oral Cavity Carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
734
|
172
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2011 |
Ovarian Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
539
|
19
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Oral Cavity Carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
167
|
16
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant neoplasm of mouth
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
756
|
184
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
HER2-positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
288
|
26
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |